Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.

导出 LinkOut

翻译打印收藏纠错

作者： Steven,Law ^[1] ; Aviva,Petrie ^[2] ; Liza,Chacko ^[1] ; Oliver C,Cohen ^[1] ; Sriram,Ravichandran ^[1] ; Janet A,Gilbertson ^[1] ; Dorota,Rowczenio ^[1] ; Ashutosh,Wechalekar ^[1] ; Ana,Martinez-Naharro ^[1] ; Helen J,Lachmann ^[1] ; Carol J,Whelan ^[1] ; David F,Hutt ^[1] ; Philip N,Hawkins ^[1] ; Marianna,Fontana ^[1] ; Julian D,Gillmore ^[1]

作者单位： National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK. ^[1] Eastman Dental Institute, University College London, London, UK. ^[2]

关键词 Amyloid Amyloidosis Cardiomyopathy Staging TTR Transthyretin

DOI 10.1002/ehf2.12989

PMID 32924285

发布时间 2022-11-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

ESC heart failure

2020年7卷6期

3942-3949页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.

ESC heart failure

相似文献

ESC heart failure

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.

ESC heart failure

相似文献

ESC heart failure

相关期刊

检索历史清除